Donald L. Wood is a pharmacist who is specialized in Pharmacotherapy in Spokane, Washington. Patients can reach him at 104 W 5th Ave, Atten. Shmc Anticoagulation Clinic, Spokane or contact him on 509-474-2232. Active license number of Donald L. Wood is PH00010028 for Pharmacotherapy in Washington. Donald L. Wood is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Donald L. Wood speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Donald L. Wood are as mentioned below.
NPI Number:
1396811303
NPI Enumeration Date:
28 Nov, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Donald L. Wood are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
PH00010028
Washington
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
104 W 5th Ave, Atten. Shmc Anticoagulation Clinic Spokane, Washington
Zip:
99204-4880
Phone Number:
509-474-2232
Fax Number:
509-474-2233
Patients can reach Donald L. Wood at 104 W 5th Ave, Atten. Shmc Anticoagulation Clinic, Spokane, Washington or can call on phone at 509-474-2232.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.